Recent Ruling Clarifies Patent Litigation Timing Under Biosimilars Act
By EsqSocial Corporation 27/11/13
The first court decision interpreting the Biosimilars Act has arrived, with a federal district court in California finding that a biosimilar application must be filed with the FDA before patent litigation can be initiated. This ruling may have...
By: Goodwin Procter LLP